Peptide Analogs Capable of Enhancing Stimulation of a Glioma-specific Ctl Response

The invention provides a peptide derived from the interleukin-13 receptor alpha2, which serves as a HLA-A2-restricted cytotoxic T lymphocyte (CTL) epitope. The invention can be used as a vaccine for glioma and can be formulated into compositions for medical or veterinary use. In addition, the invention provides the use of a peptide derived from the Eph family of tyrosine kinase receptors which can be also used as a vaccine for glioma and can be formulated into compositions for medical or veterinary use.

Attached files:
US 20100008940.jpg

Patents:
US 20,100,008,940

Inventor(s): OKADA HIDEHO [US]; STORKUS WALTER J [US]; EGUCHI JUNICHI [US]; SATO HIDEMITSU [JP]

Type of Offer: Licensing



Next Patent »
« More Veterinary Science Patents

Share on      


CrowdSell Your Patent